The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Advances in Non-Viral DNA Vectors for Gene Therapy
Open accessAbstract
Uses of viral vectors have thus far eclipsed uses of non-viral vectors for gene therapy delivery in the clinic. Viral vectors, however, have certain issues involving genome integration, the inability to be delivered repeatedly, and possible host rejection. Fortunately, development of non-viral DNA vectors has progressed steadily, especially in plasmid vector length reduction, now allowing these tools to fill in specifically where viral or other non-viral vectors may not be the best options. In this review, we examine the improvements made to non-viral DNA gene therapy vectors, highlight opportunities for their further development, address therapeutic needs for which their use is the logical choice, and discuss their future expansion into the clinic
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 1×
“The enormous potential for plasmids as non-viral vectors for gene therapy has been recognized since at least 1990 [21].”
BackgroundCpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“Lentiviral and retroviral vectors, which are designed for insertion into the genome, bring a high risk of gene disruption [10,11].”
BackgroundOrganization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold
Mirkovitch, J., Mirault, M.-E., & Laemmli, U. K. (1984) · Cell · doi:10.1016/0092-8674(84)90208-3 · Cited by 1,066
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733
Zanta, M. A., Belguise-Valladier, P., & Behr, J.-P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.91 · Cited by 722
Ahmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Vollmer, J., & Krieg, A. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.008 · Cited by 585
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
Wold, W., & Toth, K. (2014) · Current Gene Therapy · doi:10.2174/1566523213666131125095046 · Cited by 555
MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
Hu, S., Huang, M., Li, Z., Jia, F., Ghosh, Z., Lijkwan, M. A., Fasanaro, P., Sun, N., Wang, X., Martelli, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.928424 · Cited by 462
A peptide nucleic acid–nuclear localization signal fusion that mediates nuclear transport of DNA
Brandén, L. J., Mohamed, A. J., & Smith, C. I. E. (1999) · Nature Biotechnology · doi:10.1038/11726 · Cited by 375
Nikol, S., Baumgartner, I., Van Belle, E., Diehm, C., Visoná, A., Capogrossi, M. C., Ferreira-Maldent, N., Gallino, A., Graham Wyatt, M., Dinesh Wijesinghe, L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.33 · Cited by 333
Scheiermann, J., & Klinman, D. M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.065 · Cited by 322
Universal strategies in research and drug discovery based on protein-fragment complementation assays
Michnick, S. W., Ear, P. H., Manderson, E. N., Remy, I., & Stefan, E. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2311 · Cited by 319
Kreiss, P. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.19.3792 · Cited by 279
Monjezi, R., Miskey, C., Gogishvili, T., Schleef, M., Schmeer, M., Einsele, H., Ivics, Z., & Hudecek, M. (2017) · Leukemia · doi:10.1038/leu.2016.180 · Cited by 258
A new DNA vehicle for nonviral gene delivery: supercoiled minicircle
Darquet, A.-M., Cameron, B., Wils, P., Scherman, D., & Crouzet, J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300540 · Cited by 249
Kreppel, F., & Kochanek, S. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300321 · Cited by 237
Li, S., Wu, S.-P., Whitmore, M., Loeffert, E. J., Wang, L., Watkins, S. C., Pitt, B. R., & Huang, L. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l796 · Cited by 225
Recent progress in nanomaterials for gene delivery applications
Keles, E., Song, Y., Du, D., Dong, W.-J., & Lin, Y. (2016) · Biomaterials Science · doi:10.1039/c6bm00441e · Cited by 213
Mwau, M., Cebere, I., Sutton, J., Chikoti, P., Winstone, N., Wee, E. G.-T., Beattie, T., Chen, Y.-H., Dorrell, L., McShane, H., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.19701-0 · Cited by 207
The Mucus Barrier to Inhaled Gene Therapy
Duncan, G. A., Jung, J., Hanes, J., & Suk, J. S. (2016) · Molecular Therapy · doi:10.1038/mt.2016.182 · Cited by 188
Chen, Z.-Y., Riu, E., He, C.-Y., Xu, H., & Kay, M. A. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300399 · Cited by 159
Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer
Darquet, A.-M., Rangara, R., Kreiss, P., Schwartz, B., Naimi, S., Delaère, P., Crouzet, J., & Scherman, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300816 · Cited by 158
Bigger, B., Tolmachov, O. E., Collombet, J.-M., Fragkos, M., Palaszewski, I., & Coutelle, C. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010873200 · Cited by 149
Episomal vectors for gene expression in mammalian cells
Van Craenenbroeck, K., Vanhoenacker, P., & Haegeman, G. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01645.x · Cited by 147
Cranenburgh, R. M., Hanak, J. A., Williams, S. G., & Sherratt, D. J. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.5.e26 · Cited by 135
Designing Nonviral Vectors for Efficient Gene Transfer and Long-Term Gene Expression
Jackson, D. A., Juranek, S., & Lipps, H. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.026 · Cited by 119
New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy Trials
Vandermeulen, G., Marie, C., Scherman, D., & Véronique Préat, A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.182 · Cited by 113
Faurez, F., Dory, D., Moigne, V. L., Gravier, R., & Jestin, A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.040 · Cited by 113
Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system
Luke, J. M., Carnes, A. E., Hodgson, C. P., & Williams, J. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.017 · Cited by 112
Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes
Remaut, K., Sanders, N. N., Fayazpour, F., Demeester, J., & Smedt, S. C. D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.009 · Cited by 110
pCOR: a new design of plasmid vectors for nonviral gene therapy
Soubrier, F., Cameron, B., Manse, B., Somarriba, S., Dubertret, C., Jaslin, G., Jung, G., Caer, C. L., Dang, D., Mouvault, J. M., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300968 · Cited by 108
Minicircle DNA vectors for gene therapy: advances and applications
Gaspar, V. M., de Melo‐Diogo, D., Costa, E. C., Moreira, A. F., Queiroz, J. A., Pichon, C., Correia, I. J., & de Sousa, F. P. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.996544 · Cited by 104
Mechanisms of Theta Plasmid Replication
Lilly, J., & Camps, M. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0029-2014 · Cited by 102
Ullmann, A., Perrin, D., Jacob, F., & Monod, J. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80338-2 · Cited by 102
Drozd, A. M., Walczak, M. P., Piaskowski, S., Stoczyńska-Fidelus, E., Rieske, P., & Grzela, D. P. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0112-3 · Cited by 101
Schakowski, F., Gorschlüter, M., Junghans, C., Schroff, M., Buttgereit, P., Ziske, C. G., Schöttker, B., König-Merediz, S. A., Sauerbruch, T., Wittig, B., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0322 · Cited by 98
Lentiviral-mediated phenotypic correction of cystic fibrosis pigs
Cooney, A. L., Alaiwa, M. H. A., Shah, V. S., Bouzek, D. C., Stroik, M. R., Powers, L. S., Gansemer, N. D., Meyerholz, D. K., Welsh, M. J., Stoltz, D. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.88730 · Cited by 96
Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors
Izsvák, Z. (2009) · Methods · doi:10.1016/j.ymeth.2009.07.001 · Cited by 95
Gaspar, V. M., Gonçalves, C., de Melo-Diogo, D., Costa, E. C., Queiroz, J. A., Pichon, C., Sousa, F., & Correia, I. J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.040 · Cited by 91
Gaspar, V. M., Baril, P., Costa, E. C., de Melo‐Diogo, D., Foucher, F., Queiroz, J. A., de Sousa, F. P., Pichon, C., & Correia, I. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.011 · Cited by 88
Gene therapy in the Cornea: 2005–present
Mohan, R. R., Tovey, J. C. K., Sharma, A., & Tandon, A. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.09.001 · Cited by 85
Huang, M., Nguyen, P. K. P., Jia, F., Hu, S., Gong, Y., de Almeida, P. E., Wang, L., Nag, D., Kay, M. A., Giaccia, A. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.014019 · Cited by 83
Gene Therapy of X-Linked Severe Combined Immunodeficiency
Hacein‐Bey‐Abina, S., Fischer, A., & Cavazzana, M. (2002) · International Journal of Hematology · doi:10.1007/bf02982686 · Cited by 82
Current Status of Gene Therapy for Inherited Lung Diseases
Driskell, R. R., & Engelhardt, J. F. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142426 · Cited by 78
Exploring writhe in supercoiled minicircle DNA
Fogg, J. M., Kolmakova, N. G., Rees, I., Magonov, S., Hansma, H. G., Perona, J. J., & Zechiedrich, L. (2006) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/18/14/s01 · Cited by 78
Self-citationMinicircle DNA Provides Enhanced and Prolonged Transgene Expression Following Airway Gene Transfer
Munye, M. M., Tagalakis, A. D., Barnes, J. L., Brown, R. E., McAnulty, R. J., Howe, S. J., & Hart, S. L. (2016) · Scientific Reports · doi:10.1038/srep23125 · Cited by 78
Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver
Argyros, O., Wong, S. P., Fedonidis, C., Tolmachov, O. E., Waddington, S. N., Howe, S. J., Niceta, M., Coutelle, C., & Harbottle, R. P. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0713-3 · Cited by 76
Marie, C., Vandermeulen, G., Quiviger, M., Richard, M., Véronique Préat, A., & Scherman, D. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1441 · Cited by 75
Safety and efficacy of DNA vaccines
Stenler, S., Blomberg, P., & Smith, C. E. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28077 · Cited by 74
Effects of Circular DNA Length on Transfection Efficiency by Electroporation into HeLa Cells
Hornstein, B. D., Roman, D., Arevalo-Soliz, L. M., Engevik, M. A., & Zechiedrich, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167537 · Cited by 73
Self-citationEmerging significance of plasmid DNA nuclear import in gene therapy
Munkonge, F. M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00050-4 · Cited by 72
Plasmid selection in Escherichia coli using an endogenous essential gene marker
Goh, S., & Good, L. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-61 · Cited by 72
Antibiotic-free selection in E. coli: new considerations for optimal design and improved production
Peubez, I., Chaudet, N., Mignon, C., Hild, G., Husson, S., Courtois, V., Luca, K. D., Speck, D., & Sodoyer, R. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-65 · Cited by 68
Marker-free plasmids for biotechnological applications – implications and perspectives
Oliveira, P. H., & Mairhofer, J. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.06.001 · Cited by 67
Lu, J., Zhang, F., Xu, S., Fire, A. Z., & Kay, M. A. (2012) · Molecular Therapy · doi:10.1038/mt.2012.65 · Cited by 67
Jin, C., Fotaki, G., Ramachandran, M., Nilsson, B., Essand, M., & Yu, D. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505869 · Cited by 66
TALEN gene editing takes aim on HIV
Benjamin, R., Berges, B. K., Solis‐Leal, A., Igbinedion, O., Strong, C. L., & Schiller, M. R. (2016) · Human Genetics · doi:10.1007/s00439-016-1678-2 · Cited by 66
Supercoiled Minivector DNA resists shear forces associated with gene therapy delivery
Catanese, D. J., Fogg, J. M., Schrock, D. E., Gilbert, B. E., & Zechiedrich, L. (2011) · Gene Therapy · doi:10.1038/gt.2011.77 · Cited by 63
Self-citationMairhofer, J., & Grabherr, R. M. (2008) · Molecular Biotechnology · doi:10.1007/s12033-008-9046-7 · Cited by 63
Improving DNA Vaccine Performance Through Vector Design
Williams, J. (2014) · Current Gene Therapy · doi:10.2174/156652321403140819122538 · Cited by 63
Minicircle DNA is Superior to Plasmid DNA in Eliciting Antigen-specific CD8+ T-cell Responses
Dietz, W., Skinner, N., Hamilton, S. E., Jund, M. D., Heitfeld, S. M., Litterman, A. J., Hwu, P., Chen, Z.-Y., Salazar, A. Μ., Ohlfest, J. R., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.85 · Cited by 62
Mairhofer, J., Cserjan‐Puschmann, M., Striedner, G., Nöbauer, K., Razzazi‐Fazeli, E., & Grabherr, R. M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.025 · Cited by 61
A Mini-intronic Plasmid (MIP): A Novel Robust Transgene Expression Vector In Vivo and In Vitro
Lu, J., Zhang, F., & Kay, M. A. (2013) · Molecular Therapy · doi:10.1038/mt.2013.33 · Cited by 57
Garmory, H. S., Leckenby, M. W., Griffin, K. F., Elvin, S. J., Taylor, R. R., Hartley, M. G., Hanak, J. A. J., Williamson, E. D., & Cranenburgh, R. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2005-2011.2005 · Cited by 57
Gene therapy for cystic fibrosis: an example for lung gene therapy
Uta Griesenbach, D., Geddes, D. M., & Alton, E. W. F. W. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302368 · Cited by 56
Functions of noncoding sequences in mammalian genomes
Patrushev, L. I., & Kovalenko, T. F. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914130021 · Cited by 55
Samson, S. L., Gonzalez, E. V., Yechoor, V., Bajaj, M., Oka, K., & Chan, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.198 · Cited by 54
Szpirer, C., & Milinkovitch, M. C. (2005) · BioTechniques · doi:10.2144/05385rr02 · Cited by 53
Zhao, N., Fogg, J. M., Zechiedrich, L., & Zu, Y. (2010) · Gene Therapy · doi:10.1038/gt.2010.123 · Cited by 53
Self-citationDetecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker
Ronald, J. A., Chuang, H., Dragulescu‐Andrasi, A., Hori, S. S., & Gambhir, S. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414156112 · Cited by 52
Sonoporation of the Minicircle-VEGF165 for Wound Healing of Diabetic Mice
Yoon, C. S., Jung, H. S., Kwon, M. J., Lee, S. Y., Kim, C. W., Kim, M.-K., Lee, M., & Park, J. H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9778-x · Cited by 52
Nuclear‐targeted minicircle to enhance gene transfer with non‐viral vectors in vitro and in vivo
Vaysse, L., Gregory, L. G., Harbottle, R. P., Pérouzel, É., Tolmachov, O. E., & Coutelle, C. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.883 · Cited by 49
Wang, Q., Jiang, W., Chen, Y., Liu, P., Sheng, C., Chen, S., Zhang, H., Pan, C., Gao, S., & Huang, W. (2013) · Journal of Virology · doi:10.1128/jvi.02757-13 · Cited by 46
Cranenburgh, R. M., Lewis, K. S., & Hanak, J. A. J. (2004) · Microbial Physiology · doi:10.1159/000079828 · Cited by 45
Gaspar, V. M., Moreira, A. F., Costa, E. C., Queiroz, J. A., de Sousa, F. P., Pichon, C., & Correia, I. J. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.004 · Cited by 44
(2005) · Wiley eBooks · doi:10.1002/9783527620982 · Cited by 44
Zibert, J. R., Wallbrecht, K., Schön, M., Mir, L. M., Jacobsen, G. K., Trochon-Joseph, V., Bouquet, C., Villadsen, L. S., Cadossi, R., Skov, L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41295 · Cited by 43
Martínez-Alonso, S., Martínez‐López, A., Estepa, A., Cuesta, A., & Tafalla, C. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.073 · Cited by 39
Alton, E. W. F. W., Boyd, A., Cheng, S. H., Davies, J. C., Davies, L. A., Dayan, A. D., Gill, D. R., Uta Griesenbach, D., Higgins, T., Hyde, S. C., et al. (2013) · Gene Therapy · doi:10.1038/gt.2013.61 · Cited by 39
Verghese, S. C., Goloviznina, N. A., Skinner, A. M., Lipps, H. J., & Kurre, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku082 · Cited by 38
Minimal size MIDGE vectors improve transgene expression in vivo.
Schakowski, F., Gorschlüter, M., Buttgereit, P., Märten, A., von Lilienfeld‐Toal, M., Junghans, C., Schroff, M., König-Merediz, S. A., Ziske, C. G., Strehl, J., et al. (2007) · PubMed · Cited by 36
Progress and Prospects: prospects of repeated pulmonary administration of viral vectors
Sinn, P. L., Burnight, E. R., & McCray, P. B. (2009) · Gene Therapy · doi:10.1038/gt.2009.87 · Cited by 35
Stenler, S., Wiklander, O. P. B., Tejedor, M. B., Turunen, J. J., Nordin, J. Z., Hallengärd, D., Wahrén, B., Andaloussi, S. E., Rutland, M. W., Smith, C. E., et al. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.67 · Cited by 34
Lijkwan, M. A., Hellingman, A. A., Bos, E. J., van der Bogt, K. E. A., Huang, M., Kooreman, N. G., de Vries, M. R., Peters, H. A. B., Robbins, R. C., Hamming, J. F., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.110 · Cited by 34
DNA Ministrings: Highly Safe and Effective Gene Delivery Vectors
Nafissi, N., Alqawlaq, S., Lee, E. A., Földvári, M., Spagnuolo, P. A., & Slavcev, R. A. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.16 · Cited by 34
Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
Gaspar, V. M., Maia, C. J., Queiroz, J. A., Pichon, C., Correia, I. J., & de Sousa, F. P. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.020 · Cited by 34
Towards effective non-viral gene delivery vector
Šimčíková, M., Prather, K. L. J., Prazeres, D. M. F., & Monteiro, G. A. (2015) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2016.1178011 · Cited by 33
Production of a new DNA vehicle for gene transfer using site-specific recombination
Kreiss, P., Cameron, B., Darquet, A.-M., Scherman, D., & Crouzet, J. (1998) · Applied Microbiology and Biotechnology · doi:10.1007/s002530051213 · Cited by 32
Pang, X., Ma, F., Zhang, P., Zhong, Y., Zhang, J., Wang, T., Zheng, G., Hou, X., Zhao, J., He, C., et al. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.122 · Cited by 32
A Genetically Encoded AND Gate for Cell-Targeted Metabolic Labeling of Proteins
Mahdavi, A., Segall-Shapiro, T. H., Kou, S., Jindal, G. A., Hoff, K. G., Liu, S., Chitsaz, M., Ismagilov, R. F., Silberg, J. J., & Tirrell, D. A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400448f · Cited by 31
Borggren, M., Nielsen, J. O., Bragstad, K., Karlsson, I., Krog, J. S., Williams, J. A., & Fomsgaard, A. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1011987 · Cited by 30
Development of rAAV2-CFTR: History of the First rAAV Vector Product to be Used in Humans
Loring, H. S., ElMallah, M. K., & Flotte, T. R. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2015.150 · Cited by 29
Sustained Expression from DNA Vectors
Wong, S. P., Argyros, O., & Harbottle, R. P. (2014) · Advances in genetics · doi:10.1016/bs.adgen.2014.11.002 · Cited by 29
Cardiac gene therapy: are we there yet?
Matkar, P. N., Leong-Poi, H. M., & Singh, K. K. (2016) · Gene Therapy · doi:10.1038/gt.2016.43 · Cited by 28
Nafissi, N., & Slavcev, R. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-154 · Cited by 27
Stenler, S., Andersson, A., Simonson, O. E., Lundin, K. E., Chen, Z.-Y., Kay, M. A., Smith, C. I. E., Sylvén, C., & Blomberg, P. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318194234e · Cited by 27
Nuclear Scaffold Attachment Sites within ENCODE Regions Associate with Actively Transcribed Genes
Keaton, M., Taylor, C. M., Layer, R. M., & Dutta, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017912 · Cited by 27
Gene Therapy of X-Linked Severe Combined Immunodeficiency
Hacein‐Bey‐Abina, S., Basile, G. D. S., & Cavazzana, M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-345-3:247 · Cited by 26
Wang, H., Chen, Z., Zhang, G., Ou, X., Yang, X., Wong, C. K. C., Giesy, J. P., Du, J., & Chen, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047159 · Cited by 25
Endmann, A., Baden, M., Weisermann, E., Kapp, K., Schroff, M., Kleuss, C., Wittig, B., & Juhls, C. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.034 · Cited by 25
A New Strategy to Deliver Synthetic Protein Drugs: Self-reproducible Biologics Using Minicircles
Yi, H., Kim, Y., Kim, J., Jung, H., Rim, Y. A., Jung, S. M., Park, S., & Ju, J. H. (2014) · Scientific Reports · doi:10.1038/srep05961 · Cited by 25
Hou, X., Guo, X., Chen, Y., He, C., & Chen, Z. (2015) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.62 · Cited by 25
Improvement of pCOR plasmid copy number for pharmaceutical applications
Soubrier, F., Laborderie, B., & Cameron, B. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1729-9 · Cited by 24
Xu, H. H., Real, L. J., & Bailey, M. W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.166 · Cited by 23
Pfaffenzeller, I., Mairhofer, J., Striedner, G., Bayer, K., & Grabherr, R. M. (2006) · Biotechnology Journal · doi:10.1002/biot.200600017 · Cited by 22
Huang, J.-M., Sali, M., Leckenby, M. W., Radford, D. S., Huynh, H. A., Delogu, G., Cranenburgh, R. M., & Cutting, S. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.001 · Cited by 22
Minicircle: Next Generation DNA Vectors for Vaccination
Schleef, M., Schirmbeck, R., Reiser, M. L., et al. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2727-2_18 · Cited by 22
Development of a nicking endonuclease-assisted method for the purification of minicircles
Alves, C. P. A., Šimčíková, M., Brito, L., Monteiro, G. A., & Prazeres, D. M. F. (2016) · Journal of Chromatography A · doi:10.1016/j.chroma.2016.03.035 · Cited by 21
Xu, Z., Chen, F., Zhang, L., Lu, J., Xu, P., Liu, G., Xie, X., Mu, W., Wang, Y., & Liu, D. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0067-0 · Cited by 20
Rao, R. C., & Zacks, D. N. (2014) · Developments in ophthalmology · doi:10.1159/000357376 · Cited by 20
Köchling, J., Prada, J., Bahrami, M., Stripecke, R., Seeger, K., Henze, G., Wittig, B., & Schmidt, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.094 · Cited by 20
Minicircle and Miniplasmid DNA Vectors
(2013) · Wiley eBooks · doi:10.1002/9783527670420 · Cited by 20
Episomal Maintenance of S/MAR-Containing Non-Viral Vectors for RPE-Based Diseases
Koirala, A., Conley, S. M., & Naash, M. I. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_88 · Cited by 19
Witzenbichler, B., Mahfoudi, A., Soubrier, F., Roux, A. L., Branellec, D., Schultheiss, H., & Isner, J. M. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0031-3 · Cited by 19
Lung gene therapy—How to capture illumination from the light already present in the tunnel
Xia, E., Munegowda, M. A., Cao, H., & Hu, J. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.06.001 · Cited by 18
Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector
Rim, Y. A., Yi, H., Kim, Y., Park, N., Jung, H., Kim, J., Jung, S. M., Park, S., & Ju, J. H. (2014) · Scientific Reports · doi:10.1038/srep06935 · Cited by 17
Fernandes, A. R., & Chari, D. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.039 · Cited by 17
Contemporary approaches for nonviral gene therapy.
Jones, C. H., Hill, A. B., Chen, M., & Pfeifer, B. A. (2015) · PubMed · Cited by 16
Bazzani, R. P., Pringle, I. A., Connolly, M. M., Davies, L. A., Jones, S., Schleef, M., Hyde, S. C., & Gill, D. R. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.029 · Cited by 16
Šimčíková, M., Alves, C. P. A., Brito, L., Prather, K. L. J., Prazeres, D. M. F., & Monteiro, G. A. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7565-x · Cited by 15
Minicircle DNA purification using a CIM® DEAE‐1 monolithic support
Diamantino, T., Pereira, P., Queiroz, J. A., Sousa, Â., & de Sousa, F. P. (2016) · Journal of Separation Science · doi:10.1002/jssc.201600375 · Cited by 15
Hou, X., Jiao, R., Guo, X., Wang, T., Chen, P., Wang, D., Chen, Y., He, C.-Y., & Chen, Z.-Y. (2016) · Gene Therapy · doi:10.1038/gt.2016.37 · Cited by 14
Jiang, X., Yu, H., Teo, C. R., Tan, G. S. X., Goh, S. C., Patel, P. S., Chua, Y. K., Hameed, N. B. S., Bertoletti, A., & Patzel, V. (2016) · Molecular Therapy · doi:10.1038/mt.2016.138 · Cited by 14
Development of Antibiotic-Free Selection System for Safer DNA Vaccination
Luke, J. M., Carnes, A. E., & Williams, J. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0410-5_6 · Cited by 13
Tolmachov, O. E. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.10.035 · Cited by 12
Sum, C. H., Nafissi, N., Slavcev, R. A., & Wettig, S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142875 · Cited by 11
Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection.
Ghasemi, F., Rostami, S., Ghayour‐Mobarhan, M., & Meshkat, Z. (2016) · PubMed Central · Cited by 11
Bathula, S. R., & Huang, L. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc073.pub2 · Cited by 7
Li, J., Shi, J., Wu, X., Fu, F., Yu, J., Yuan, X., Peng, Z., Cong, X., Xu, S., Sun, W., et al. (2015) · Viral Immunology · doi:10.1089/vim.2014.0121 · Cited by 7
"Dressed-up" naked plasmids: emerging vectors for non-viral gene therapy.
Górecki, D. C. (2006) · PubMed · Cited by 7
MIDGE Vectors and dSLIM Immunomodulators: DNA‐based Molecules for Gene Therapeutic Strategies
Schmidt, M., Volz, B., & Wittig, B. (2005) · Wiley eBooks · doi:10.1002/9783527620982.ch7 · Cited by 6
Daneshvar, N., Abdullah, R., Shamsabadi, F. T., Moeini, H., Mehrboud, P., Rahman, H. S., Boroojerdi, M. H., & Vellasamy, S. (2015) · Tissue and Cell · doi:10.1016/j.tice.2015.04.005 · Cited by 6
An EBV ‐based plasmid can replicate and maintain in stem cells
Rad, S. M. A. H., Bamdad, T., Arefian, E., Mohammadi, M. M., & Sadeghizadeh, M. (2015) · Biotechnology Progress · doi:10.1002/btpr.2153 · Cited by 2
Cited by
Graphene Quantum Dots and Their Applications in Bioimaging, Biosensing, and Therapy
Chung, S., Revia, R. A., & Zhang, M. (2021) · Advanced Materials · doi:10.1002/adma.201904362 · Cited by 739
DNA Vaccines—How Far From Clinical Use?
Hobernik, D., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113605 · Cited by 457
Polymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Santa Chalarca, C. F., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 365
Transfection types, methods and strategies: a technical review
Chong, Z. X., Yeap, S. K., & Ho, W. Y. (2021) · PeerJ · doi:10.7717/peerj.11165 · Cited by 303
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Kim, B., Park, J., & Sailor, M. J. (2019) · Advanced Materials · doi:10.1002/adma.201903637 · Cited by 298
Metadata
- Authors
- Hardee, C., Arévalo-Soliz, L., Hornstein, B., & Zechiedrich, L.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2017-02-10
- Volume
- 8
- Issue
- 2
- Pages
- 65
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W2589094119
- Cited by
- 356
- References
- 141
- FWCI
- 14.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.